FDA expects CPR applications for COVID-19 vaccines by late 2021

The Philippine FDA expects applications for commercial distribution of COVID-19 vaccines by late 2021.

Eric Domingo, FDA director-general, stated that companies must complete phase 3 trials before applying for a certificate of product registration (CPR).

Moderna's vaccine received emergency use authorization on May 5, making it the seventh approved in the Philippines.

The benefits of Moderna’s vaccine outweigh potential risks with an efficacy rate over 94%.

Philippines procured around 13 million doses from Moderna while private sector ordered seven million; close to 200,000 doses will be delivered in June.